Combination of CDK4/6 inhibitor PD-0332991 with standard chemotherapy is synergistic in RB high pancreatic cancer. (July 2016) - Chou, A.; Steinmann, A.; Froio, D.; Drury, A.; Wohl, D.; Chin, V.; Nagrial, A.; Gill, A.; Pajic, M.